Development and validation of a risk nomogram model for predicting pulmonary hypertension in patients with stage 3-5 chronic kidney disease.

Yue HuXiaotong WangShengjue XiaoHuimin WuChunyan HuanTao XuMinjia GuoAilin LiuXiaoyao JiangJia WangHong ZhuDefeng Pan

Published in: International urology and nephrology (2022)

The evaluation of the nomogram model for predicting PAH in patients with CKD based on risk factors showed its ideal efficacy. Thus, the nomogram can be used to screen for patients at high risk for PAH and has guiding value for the subsequent formulation of prevention strategies and clinical treatment.

Keyphrases

chronic kidney disease
end stage renal disease
pulmonary hypertension
risk factors
lymph node metastasis
peritoneal dialysis
newly diagnosed
ejection fraction
prognostic factors
drug delivery
pulmonary artery
squamous cell carcinoma
pulmonary arterial hypertension
single cell
replacement therapy